Safeguarding Health in Hong Kong: BioGerm × LABNOVATION Featured at Hong Kong Community Health Day

On August 1, 2026, the "LOHAS Central & Western District Health Day"—hosted by the Water Street Area Care Team and funded by the Home Affairs Department of the Hong Kong SAR Government—was successfully held at the Sai Ying Pun Community Complex.

BioGerm supported the event with the flagship LD-100 Glycated Hemoglobin (HbA1c) Analyzer from its chronic disease management sub-brand, LABNOVATION, delivering high-quality HbA1c screening services to hundreds of local elderly residents.

3 Minutes, 1 Drop of Fingerstick Blood, 3 Months of Real Glycemic Control Insights

Evidence-based medicine is bringing the "gold standard" into everyday community care. BioGerm LABNOVATION LD-100 delivers a mobile Point-of-Care solution designed to address key pain points in community chronic disease screening:

 No Fasting Required: Requires only 4 μL of capillary blood for a comfortable finger-prick collection.

Rapid 3-Minute Test: Delivers instant on-site results, significantly reducing waiting time.

Eliminates Blind Spots: HbA1c reflects long-term glycemic control, overcoming the limitations of traditional spot testing.

Internationally Traceable: Dual-certified by NGSP and IFCC, featuring high precision with CV≤2.5%.

Precision technology meets compassionate care. Beyond reliable testing, our team offered attentive health counseling and chronic disease education—earning high praise from the local community.

Guided by our mission to "Empowering Doctors, Enhance Life" and our core value of "Gratitude & Altruism", BioGerm LABNOVATION will continue driving high-quality IVD diagnostic solutions to primary care—strengthening chronic disease management at the community frontline.